Concepedia

A. Bardia

AB

Statistics

Publications

2

Citations

70

H-Index

2

Active since

2022

Affiliations

Institut Curie(Current)

A. Bardia is an author at Institut Curie specializing in oncology, metastatic disease treatment, and breast cancer prognosis.

Publications per year

2022–2024

2

Publications

2

LBA76 Overall survival (OS) results from the phase III TROPiCS-02 study of sacituzumab govitecan (SG) vs treatment of physician's choice (TPC) in patients (pts) with HR+/HER2- metastatic breast cancer (mBC)

Hope S. Rugo, A. Bardia, F. Marmé et al. · Annals of Oncology · 2022 · 57 citations · Full text

, , +12

LBA21 Human epidermal growth factor receptor 2 (HER2)-low and HER2-ultralow status determination in tumors of patients (pts) with hormone receptor–positive (HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 (DB-06)

R.F. Salgado, A. Bardia, G. Curigliano et al. · Annals of Oncology · 2024 · 13 citations · Full text

, , +14

1–2 of 2